Welcome to LookChem.com Sign In|Join Free

CAS

  • or
Kainic acid (487-79-6) is a conformationally restricted glutamate analog that acts as a selective agonist at kainate receptors. It is a potent neuroexcitatory agent and neurotoxin, commonly used as a tool in neurobiology research. Kainic acid is also known for its ability to induce seizures in laboratory animals, making it a classic agent for studying seizure activity.

487-79-6 Suppliers

Post Buying Request

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • 487-79-6 Structure
  • Basic information

    1. Product Name: KAINIC ACID
    2. Synonyms: ,4-beta))-;2-carboxy-4-isopropenyl-3-pyrrolidineaceticaci;3-pyrrolidineaceticacid,2-carboxy-4-(1-methylethenyl)-,(2s-(2-alpha,3-beta;alpha-kainicacid;digenicacid;digenin;helminal;(2-CARBOXY-3-CARBOXYMETHYL-4-ISOPROPENYLPYRROLIDINE)
    3. CAS NO:487-79-6
    4. Molecular Formula: C10H15NO4
    5. Molecular Weight: 213.23
    6. EINECS: N/A
    7. Product Categories: Glutamate receptor
    8. Mol File: 487-79-6.mol
  • Chemical Properties

    1. Melting Point: 253-254 C
    2. Boiling Point: 353.22°C (rough estimate)
    3. Flash Point: 219.8 °C
    4. Appearance: White solid
    5. Density: 1.2177 (rough estimate)
    6. Vapor Pressure: 5.74E-09mmHg at 25°C
    7. Refractive Index: 1.4368 (estimate)
    8. Storage Temp.: 2-8°C
    9. Solubility: H2O: soluble
    10. PKA: 2.03±0.60(Predicted)
    11. Stability: Stable for 1 year from date of purchase as supplied. Solutions in distilled water may be stored at -20° for up to 3 months.
    12. CAS DataBase Reference: KAINIC ACID(CAS DataBase Reference)
    13. NIST Chemistry Reference: KAINIC ACID(487-79-6)
    14. EPA Substance Registry System: KAINIC ACID(487-79-6)
  • Safety Data

    1. Hazard Codes: Xn
    2. Statements: 20/21/22
    3. Safety Statements: 22-24/25-36
    4. WGK Germany: 3
    5. RTECS:
    6. HazardClass: N/A
    7. PackingGroup: N/A
    8. Hazardous Substances Data: 487-79-6(Hazardous Substances Data)

487-79-6 Usage

Uses

Used in Pharmaceutical Industry:
Kainic acid is used as an excitatory amino acid and neurotoxin for the development and testing of drugs targeting the central nervous system. Its ability to induce seizures in laboratory animals makes it a valuable tool for understanding the mechanisms behind epilepsy and other seizure disorders.
Used in Neurobiology Research:
Kainic acid is used as a neurobiology tool to study the effects of glutamate receptor activation on neuronal function and the underlying mechanisms of neurodegenerative diseases. It helps researchers investigate the role of kainate receptors in various brain regions and their contribution to cognitive and motor functions.
Used in Veterinary Medicine:
Kainic acid is used as an anthelmintic, specifically for the treatment of parasitic worm infections in animals. Its neuroexcitatory properties can help in the elimination of parasites by causing their paralysis and subsequent expulsion from the host.
Used in Neuroscience:
Kainic acid is used as a glutamate receptor agonist in neuroscience research to study the role of ionotropic glutamate receptors in various brain functions and disorders. Administration of (-)-α-Kainic Acid has been shown to increase the production of reactive oxygen species, mitochondrial dysfunction, and apoptosis in neurons, particularly in the hippocampal subregions and the hilus of the dentate gyrus. This helps researchers understand the impact of glutamate receptor activation on neuronal health and the development of neurodegenerative diseases.
Chemical Properties:
Kainic acid is soluble in 0.1 M NaOH, which is an important property for its use in various applications, including pharmaceutical and neurobiology research.

Biological Activity

Selective agonist at kainate receptors. Potent excitant and neurotoxin. Also available as part of the Kainate Receptor Tocriset? .

Purification Methods

Purify the acid by adsorbing on to a strongly acidic ion-exchange resin (Merck), elute the diacid with aqueous M NaOH, the eluate is evaporated, H2O is added, and filtered through a weakly acidic ion-exchange resin (Merck). The filtrate is then evaporated and recrystallised from EtOH. Its solubility is 0.1g in 1mL of 0.5N HCl. (±)--Kainic acid is recrystallised from H2O with m 230-260o. UV (MeOH): 219 (log 3.9); max 1HNMR (CCl4, 100MHz, Me4Si standard) : 1.64 (s 1H), 1.70 (s 3H), 3.24 (d J 7.5, 2H), 3.3-4.2 (1H), 3.70 (s 3H), 3.83 (s 3H), 4.35 (dd J 7.5, J 14.5, 1H), 5.21 (t J 7.5, 1H), 7.26 (t J 7.5, 1H). [Oppolzer & Andres Helv Chim Acta 62 2282 1979, Beilstein 22 III/IV 1523.]

References

1) Watkins et al. (1981), Excitatory amino acid transmitters; Ann. Rev. Pharmacol. Toxicol., 21 165

Check Digit Verification of cas no

The CAS Registry Mumber 487-79-6 includes 6 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 3 digits, 4,8 and 7 respectively; the second part has 2 digits, 7 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 487-79:
(5*4)+(4*8)+(3*7)+(2*7)+(1*9)=96
96 % 10 = 6
So 487-79-6 is a valid CAS Registry Number.
InChI:InChI=1/C10H15NO4/c1-5(2)7-4-11-9(10(14)15)6(7)3-8(12)13/h6-7,9,11H,1,3-4H2,2H3,(H,12,13)(H,14,15)/t6-,7+,9-/m0/s1

487-79-6SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 16, 2017

Revision Date: Aug 16, 2017

1.Identification

1.1 GHS Product identifier

Product name kainic acid

1.2 Other means of identification

Product number -
Other names KAINATE

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:487-79-6 SDS

487-79-6Relevant articles and documents

Enantioselective total synthesis of (-)-α-kainic acid

Farwick, Andreas,Helmchen, Guenter

, p. 1108 - 1111 (2010)

(Figure Presented) An enantioselective total synthesis of (-)-α-kainic acid is described. Key steps are an lr-catalyzed allylic amination with a propargyllc amine to provide an enyne and a diastereoselective intramolecular Pauson-Khand reaction. Subsequent steps involve a Baeyer-Villiger reaction, reduction of the resulting lactone, and direct Jones oxidation of a silyl ether.

Algal neurotoxin biosynthesis repurposes the terpene cyclase structural fold into an N-prenyltransferase

Chekan, Jonathan R.,McKinnie, Shaun M. K.,Moore, Bradley S.,Noel, Joseph P.

, p. 12799 - 12805 (2020)

Prenylation is a common biological reaction in all domains of life wherein prenyl diphosphate donors transfer prenyl groups onto small molecules as well as large proteins. The enzymes that catalyze these reactions are structurally distinct from ubiquitous terpene cyclases that, instead, assemble terpenes via intramolecular rearrangements of a single substrate. Herein, we report the structure and molecular details of a new family of prenyltransferases from marine algae that repurposes the terpene cyclase structural fold for the N-prenylation of glutamic acid during the biosynthesis of the potent neurochemicals domoic acid and kainic acid. We solved the X-ray crystal structure of the prenyltransferase found in domoic acid biosynthesis, DabA, and show distinct active site binding modifications that remodel the canonical magnesium (Mg2+)-binding motif found in terpene cyclases. We then applied our structural knowledge of DabA and a homologous enzyme from the kainic acid biosynthetic pathway, KabA, to reengineer their isoprene donor specificities (geranyl diphosphate [GPP] versus dimethylallyl diphosphate [DMAPP]) with a single amino acid change. While diatom DabA and seaweed KabA enzymes share a common evolutionary lineage, they are distinct from all other terpene cyclases, suggesting a very distant ancestor to the larger terpene synthase family.

High-pressure Diels-Alder approach to natural kainic acid

Pandey, Sushil K.,Orellana, Arturo,Greene, Andrew E.,Poisson, Jean-Francois

, p. 5665 - 5668 (2006)

The first Diels-Alder based synthesis of (-)-kainic acid is described. Danishefsky's diene and a vinylogous malonate derived from 4-hydroxyproline combine under high pressure to afford a key bicyclic intermediate with virtually no loss of enantiopurity. This adduct can be converted into the natural product with complete stereocontrol.

Total Synthesis of (-)-α-Kainic Acid

Cooper, Jeremy,Knight, David W.,Gallagher, Peter T.

, p. 553 - 560 (1992)

N-Alkylation of the β-amino acid derivative 16, derived from (L)-aspartic acid, by the allylic chloride 12b followed by deprotection and lactonization leads to the nine-membered azalactone 18.Enolate Claisen rearrangement of this leads stereospecifically, via a boat-like transition state (cf. 6), to the pyrrolidine acid 19; subsequent one-carbon homologation, oxidation and deprotection affords (-)-(α)-kainic acid 1.

Enantioselective total synthesis of (-)-kainic acid and (+)-acromelic acid C: Via Rh(i)-catalyzed asymmetric enyne cycloisomerization

Lei, Honghui,Xin, Shan,Qiu, Yifan,Zhang, Xumu

, p. 727 - 730 (2018)

A diversity-oriented synthetic strategy was developed for the total synthesis of kainoid amino acids, which led to the enantioselective synthesis of (-)-kainic acid and the first total synthesis of (+)-acromelic acid C. Rh(i)-catalyzed asymmetric enyne cycloisomerization served as the key reaction in this strategy for the rapid construction of highly functionalized lactam, and the resulting vinyl acetate moiety was further utilized as a versatile building block for the installation of both isopropylidene and 2-pyridone units existing in natural kainoids.

Scalable Biosynthesis of the Seaweed Neurochemical, Kainic Acid

Chekan, Jonathan R.,McKinnie, Shaun M. K.,Moore, Malia L.,Poplawski, Shane G.,Michael, Todd P.,Moore, Bradley S.

, p. 8454 - 8457 (2019/05/21)

Kainic acid, the flagship member of the kainoid family of natural neurochemicals, is a widely used neuropharmacological agent that helped unravel the key role of ionotropic glutamate receptors, including the kainate receptor, in the central nervous system. Worldwide shortages of this seaweed natural product in the year 2000 prompted numerous chemical syntheses, including scalable preparations with as few as six-steps. Herein we report the discovery and characterization of the concise two-enzyme biosynthetic pathway to kainic acid from l-glutamic acid and dimethylallyl pyrophosphate in red macroalgae and show that the biosynthetic genes are co-clustered in genomes of Digenea simplex and Palmaria palmata. Moreover, we applied a key biosynthetic α-ketoglutarate-dependent dioxygenase enzyme in a biotransformation methodology to efficiently construct kainic acid on the gram scale. This study establishes both the feasibility of mining seaweed genomes for their biotechnological prowess.

Synthesis of (±)-β-Allokainic Acid

Piotrowski, Mathew L.,Kerr, Michael A.

, p. 3122 - 3126 (2019/06/08)

The total synthesis of kainoid alkaloid, (+/–)-β-allokainic acid is reported. The key step is a vinylogous Cloke–Wilson rearrangement followed by Lewis acid and transition metal induced transformations to prepare a highly functionalized pyrrolidine suitable for conversion to the target molecule.

Synthesis of Kainoids and C4 Derivatives

Tian, Zhenlin,Menard, Frederic

, p. 6162 - 6170 (2018/05/23)

A unified stereoselective synthesis of 4-substituted kainoids is reported. Four kainic acid analogues were obtained in 8-11 steps with up to 54% overall yields. Starting from trans-4-hydroxy-l-proline, the sequence enables a late-stage modification of C4 substituents with sp2 nucleophiles. Stereoselective steps include a cerium-promoted nucleophilic addition and a palladium-catalyzed reduction. A 10-step route to acid 21a was also established to enable ready functionalization of the C4 position.

Total synthesis of (-)-kainic acid and (+)-: Allo -kainic acid through SmI2-mediated intramolecular coupling between allyl chloride and an α,β-unsaturated ester

Suzuki, Junya,Miyano, Natsumi,Yashiro, Shunpei,Umezawa, Taiki,Matsuda, Fuyuhiko

, p. 6557 - 6566 (2017/08/16)

A 3,4-disubstituted pyrrolidine ring was effectively cyclized through SmI2-mediated reductive coupling between allyl chloride and an α,β-unsaturated ester, although little has been reported about SmI2-promoted C-C bond formation of an allyl chloride with an α,β-unsaturated ester. Selection of either the 3,4-cis- or 3,4-trans-selective cyclization can be accomplished simply by changing the additives from NiI2 to HMPA during reductive cyclization conducted in H2O-THF. Total synthesis of (-)-kainic acid and (+)-allo-kainic acid, which are pyrrolidine alkaloids used in neuroscience and neuropharmacology as useful molecular probes, was successfully achieved by using the stereo-complementary ring closure reactions promoted by SmI2 for the construction of the 2,3,4-trisubsituted pyrrolidine scaffold of kainoids.

Synthetic method of kainic acid

-

Paragraph 0012, (2016/10/07)

The invention discloses a synthetic method of kainic acid. The synthetic method comprises the steps of carrying out single-step series connection N-allylation-SN2' reaction on (S)-5-oxo-tetrahydrofuran-3-carbamic acid benzyl ester as a raw material to construct a kainic acid core framework-trans-2,3-cis-3,4-trans-trisubstituted pyrrolidine intermediate, reducing and oxidizing an ester group in the intermediate into an aldehyde group, carrying out Horner-Wordsworth-Emmons reaction and mercury ion accelerated methanol hydrolysis reaction to obtain the ester group added with a carbon atom, finally carrying out ester exchange, oxidization and hydrolysis, so as to obtain kainic acid. The synthetic method has the beneficial effects that the raw material cost is low, the reaction steps are short, the operation process is simple and convenient, the total yield of kainic acid is high, the synthetic cost of kainic acid can be greatly lowered, and the industrial production of kainic acid is hopefully realized.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 487-79-6